The American Journal of Managed Care

Identifying Rational Immunotherapy Combinations for Glioblastoma: A Progress Report

Leading global experts believe that for immunotherapy to work in glioblastoma—which has an estimated 5-year survival rate of 33% in the United States—combination treatments are the way ...
ascopubs.org

Identifying molecular targets for rational immunosuppressive strategies in patients with immune checkpoint therapy-induced myocarditis and myositis.

First-line treatment of fecal microbiota transplantation for immune-mediated colitis. Baseline autoantibody profiling in patients with NSCLC with pre-existing autoimmune diseases or who had received ...
GEN

Identifying New Gene-Expression Patterns

Analyzing XpressWay Human Expression Data with OmniViz Visual Analytics Software The sequencing of the human genome has identified a vast number of potentially interesting targets for drug development ...
ascopubs.org

Gene expression analysis of tumor biopsies from a trial of durvalumab to identify subsets of NSCLC with shared immune pathways.

Germ-line biomarkers disrupting microRNA regulatory pathways to predict toxicity and response to anti-PD-1 and anti-PD-L1 therapies. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting ...